West Cumbrian MP Jamie Reed has this week hosted an event in Parliament on behalf of the Juvenile Diabetes Research Foundation (JDRF). The charity, for whom Jamie Reed ran the London Marathon last weekend, works to fund world class research to prevent, treat and cure type 1 diabetes, as well as empowering and supporting people living with the condition and their families.
The #Type1Catalyst Event brought together children and families living with type 1 diabetes, researchers, funders and medical practitioners for the launch of ‘Type 1 Research Today’, a report by JDRF.
The report paints a positive picture of UK research into the condition and reveals that seven funders have committed funding to tackle the condition, amounting to £97m in the UK. It explains that institutions and funders can maximise value through greater communication and partnership, calling on the UK funding ‘ecosystem’ to be protected and enhanced.
The #Type1Catalyst Event came as the National Institute for Health Research announced further funding support for researchers investigating type 1 diabetes immunotherapies.
Type 1 diabetes affects about 400,000 people in the UK, including 29,000 children. Speaking at the event, Jamie Reed MP explained that as a type 1 diabetic himself with a 10 year old son who has recently been diagnosted with the condition, research and support for those living with type 1 diabetes is a cause particularly close to his heart. He sent a clear message to those at the at the event – that they can do anything that they want to do, and that being type 1 diabetic should never hold them back.
Copeland MP Jamie Reed said:
“Two weeks before the 2010 General Election, aged 36, I didn’t know that I was an undiagnosed type 1 diabetic entering diabetic ketoacidosis.
“The NHS saved my life, but I know that type 1 diabetes needs to be better understood, that people with the condition require a much better service than the one we currently receive, and that we must find a cure.
“That’s why I support the invaluable work undertaken by JDRF, why I will continue to champion the cause in Parliament, and why I would encourage anyone to contact their MP to ask them to do the same.“
Rachel Connor, JDRF Director of Research Partnerships said:
“Type 1 Research Today highlights the breadth of research happening around the UK to cure, treat and prevent type 1 diabetes and its complications.
“Immunotherapy research is a core strength of UK science and is critical to progress towards a world without type 1 diabetes.
“We’re therefore delighted that the NIHR is backing vital type 1 diabetes immunotherapy research”.